99 related articles for article (PubMed ID: 1004654)
1. Preliminary experience with Mitolactol in advanced tumors of the orofacial region and the larynx.
Cichý A; Grobarcíková E; Klimo J; Jurga L; Pivonka M
Neoplasma; 1976; 23(4):427-34. PubMed ID: 1004654
[TBL] [Abstract][Full Text] [Related]
2. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
3. [Combined treatment of malignant tumors of the orofacial region using intra-arterial cytostatic treatment and radiotherapy with special attention to therapeutic complications].
Hollmann K; Kogelník HD; Kühböck J; Meilath G; Seitz W
Cesk Stomatol; 1983 Jul; 83(4):268-74. PubMed ID: 6203656
[No Abstract] [Full Text] [Related]
4. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
5. Observations on dibromodulcitol (DBD)-mitolactol-treatment.
Perényl G; Büttner K; Dénes L
Ther Hung; 1977; 25(1):16-9. PubMed ID: 854865
[No Abstract] [Full Text] [Related]
6. [Prognostic factors in the treatment of inoperable orofacial tumors with simultaneous radiotherapy and intra-arterial chemotherapy].
Szepesi T; Stadler B; Hohenberg G; Hollmann K; Kühböck J; Mailath G
Strahlentherapie; 1985 May; 161(5):299-307. PubMed ID: 2408359
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of dibromodulcitol in colorectal, kidney, and other carcinomas.
Mischler NE; Tormey DC; Klotz J; Borden EC; Ramirez G; Banerjee TK; Carr RM; Zaentz SD; Graf J
Cancer Clin Trials; 1981; 4(4):407-10. PubMed ID: 7318122
[TBL] [Abstract][Full Text] [Related]
8. [Combined therapy of orofacial malignancies with radiotherapy and cytostatic agents].
Hollmann K; Mailath G; Kühböck J; Seitz W
Z Stomatol; 1984 Jun; 81(3):171-7. PubMed ID: 6206667
[No Abstract] [Full Text] [Related]
9. [Surgical-oncological aspects of combined radiation and cytostatic therapy of malignant tumors in the facial region].
Hollmann K; Kühböck J; Mailath G; Stadler B
Fogorv Sz; 1985 Sep; 78(9):268-73. PubMed ID: 3863765
[No Abstract] [Full Text] [Related]
10. Phase II study of mitolactol in metastatic malignant melanoma.
Simmonds MA; Lipton A; Harvey HA; Ellison N; White DS
Cancer Treat Rep; 1985 Jan; 69(1):65-7. PubMed ID: 3967260
[TBL] [Abstract][Full Text] [Related]
11. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
12. Results obtained with Dibromodulcitol (DBD) in the therapy of upper respiratory tract tumours.
Polyánszky T; Sellei C
Ther Hung; 1974; 22(3):112-5. PubMed ID: 4445979
[No Abstract] [Full Text] [Related]
13. [Combines cytostatic treatment of malignant tumors. (Clinical histological report of 4 cases)].
Busch W; Goldschmidt F
Krebsarzt; 1967; 22(4):224-33. PubMed ID: 5592995
[No Abstract] [Full Text] [Related]
14. [Preservation of the larynx in advanced cancer--experiences at the Oncology Department, Rambam Medical Center, Haifa].
Rosenblatt E; Siegelmann-Danieli N; Zidan J; Haim N; Kuten A
Harefuah; 2000 Oct; 139(7-8):271-4, 326. PubMed ID: 11062969
[TBL] [Abstract][Full Text] [Related]
15. Mitolactol chemotherapy for malignant melanoma: a phase II study.
Malden LT; Coates AS; Milton GW; McCarthy WH; Levi JA; Woods RL; Byrne MJ; Reynolds PM; Fox RM; Hedley DW
Cancer Treat Rep; 1984; 68(7-8):1045-6. PubMed ID: 6744338
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
Afra D; Sipos L; Vitanovics D
Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942
[TBL] [Abstract][Full Text] [Related]
17. [The role of simultaneous chemotherapy and radiotherapy in the treatment of locally metastasised tumours of the larynx, pharynx and oral cavity].
Balm AJ; Schornagel JH; Rasch CR
Ned Tijdschr Geneeskd; 2005 Jan; 149(2):61-4. PubMed ID: 15688835
[TBL] [Abstract][Full Text] [Related]
18. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
19. BCNU-DBD (Dibromodulcitol) chemotherapy of recurrent supratentorial anaplastic astrocytomas and glioblastomas.
Vitanovics D; Sipos L; Afra D
Neoplasma; 2002; 49(5):342-5. PubMed ID: 12458335
[TBL] [Abstract][Full Text] [Related]
20. Phase I--II study of hexamethylmelamine plus dibromodulcitol in refractory carcinoma of the breast.
Van Amburg AL; Presant CA; Vélez-García E; Klahr C
Cancer Treat Rep; 1979 Jan; 63(1):141-2. PubMed ID: 105806
[No Abstract] [Full Text] [Related]
[Next] [New Search]
